- According to a May 10 Metro News article, MSK employees have embraced Transportation Alternatives’ Bike to Work Challenge, “racking up 1470 miles across the city” in the first ten days. And it is not too late to join – the challenge ends on May 22.
- On another healthy note, MSK counts itself among one of the workplaces that is a member of the Farmigo community, as was mentioned in a recent Forbes interview with the startup. Farmigo is a company that delivers healthy, farm-fresh food to consumers where they work.
- On May 6, five MSK nurses and one patient care technician were honored with Rudin Awards for their outstanding service: Natalie Bell, Jaime McNally, Ethel Oliphant, Erica Fischer-Cartlidge, Rhonda D’Agostino, and Kimberly Chow.
- MSK research collaborations with other cancer centers also made the news this week:
- The Dana-Farber Cancer Institute and Boston Children’s Cancer and Blood Disorders Center joined a clinical trial led by MSK that will use gene therapy techniques to harness the power of pediatric patients’ own immune system to fight their leukemia.
- MSK’s Dr. Omar Abdel-Wahab collaborated with scientists at the Fred Hutchinson Cancer Research Center and Yale University on research that revealed that a gene mutation that alters RNA splicing is likely responsible for myelodysplastic syndrome, a condition which can be a precursor to acute myeloid leukemia.
- Project Data Sphere, a cancer clinical trial research data sharing/integrating/analyzing technology initiative that MSK has been contributing to, turned 1 year-old on May 11.
Category Archives: MSK in the News
Benefits of Molecular Imaging and More MSK in the News
- MSK radiologist, Dr. Nancy Lee and Director of MRI, Dr. Oguz Akin, were featured in an April 27 Washington Post article that explained how molecular imaging is a powerful new tool that helps make both the diagnosis and treatment of cancer more targeted.
- In an April 26 WSJ article, MSK President and CEO Dr. Craig Thompson, explained how despite cancer not yet having been “cured”, recent advances in cancer research and our ever-expanding knowledge of cancer is something to be excited and hopeful about.
- An April 23 NJBiz article announced plans for MSK to develop an outpatient cancer center in Montvale, New Jersey. This will be MSK’s third outpatient center in NJ and is scheduled to open in April 2017.
- MSK’s Computational Biology Program Chair, Dr. Chris Sander, was featured in an April 23 article summarizing the keynote address he gave in Boston at the Bio-IT World Conference & Expo. Highlighted was the work he does predicting combinations of targeted therapies to avoid the development of a cancer’s resistance to a single drug. Also mentioned was the cBioPortal visualization & analysis tool developed by his team.
Songs4Sloan Benefit Concert for Pediatric Cancer Research at MSK and More…
- On May 11 at 7pm at the Soho Playhouse (15 Vandam Street) in New York City, many of Broadway’s youngest stars will be performing as part of Songs4Sloan, a benefit concert presented by Abbey Rose Gould and Presley Ryan to benefit pediatric cancer research at MSK.
- On April 12, MSK’s Patricia Skarulis delivered a keynote address at the College of Healthcare Information Management Executives spring forum in Chicago. MSK’s ever-evolving cybersecurity strategy was discussed, which currently includes a two-factor authentication for email and various initiatives to reduce the risk of having employees fall prey to increasingly sophisticated phishing schemes.
- In an April 14 Annals of Internal Medicine paper, MSK’s Dr. Andrew Vickers, PhD, and Dr. David Kent of Tufts Medical Center argued that there may be a need for more individualized recommendations when it comes to screening and prevention as most individuals have below average risk and may experience more harm than benefit from unwarranted screenings.
- From April 22-24, MSK will be the meeting site for a workshop hosted by the International Association for the Study of Lung Cancer (IASLC). In attendance will be 100 international experts on small cell lung cancer who will discuss the current state of knowledge in this field with the goal of developing a “roadmap for future research and clinical trials for patients with this disease”.